$DH News

Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing

Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop

Definitive Healthcare (DH) Q2 2026 Earnings Call

Definitive Healthcare Corp. 2026 Q2 - Results - Earnings Call Presentation

Definitive Healthcare Corp. Q2 2026 Earnings Call Summary

Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5

Definitive Healthcare Corp (DH) (Q2 2026) Earnings Call Highlights: AI Platform Launch and ...

Definitive Healthcare Q2 Earnings Call Highlights

Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates

Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

Definitive Healthcare Reports Financial Results for Second Quarter 2026

Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.000M-$226.000M to $220.000M-$222.000M vs $223.449M Est

Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est

Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate

Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform

Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7

Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?

Definitive Healthcare: When The Anchor Shareholder Walks, Pay Attention